Strengthening the competitiveness of EU in vitro biotechnologies
The EU has been a leader in research and development of in vitro biotechnology (IVB), such as human 3D cell and tissue models used in disease research and drug development. However, it is struggling to convert scientific discoveries into business creation and competitiveness within a rapidly growing international market.
Authors
- Monica Piergiovanni (ORCID: https://orcid.org/0000-0003-4992-2068)
- Maurice Whelan
- Milena Mennecozzi (ORCID: https://orcid.org/0009-0003-2200-1477)
- Lucia Selfa Aspiroz
Institutions
- European Commission (BE)
- Joint Research Centre (IT)
Publication Details
- Journal
- Trends in biotechnology
- Published
- 2025-08-20
- DOI
- https://doi.org/10.1016/j.tibtech.2025.07.019
- Primary Topic
- Biomedical Ethics and Regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Joint Research Centre